Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 11 studies | 27% ± 11% | |
monocyte | 4 studies | 24% ± 5% | |
conventional dendritic cell | 4 studies | 25% ± 9% | |
macrophage | 4 studies | 21% ± 4% | |
neutrophil | 3 studies | 26% ± 9% | |
myeloid cell | 3 studies | 18% ± 1% | |
dendritic cell | 3 studies | 34% ± 10% |
Insufficient scRNA-seq data for expression of APOBR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2067.01 | 578 / 578 | 90% | 11.68 | 1045 / 1155 |
bladder | 86% | 738.57 | 18 / 21 | 88% | 19.85 | 446 / 504 |
prostate | 78% | 315.40 | 192 / 245 | 86% | 5.75 | 432 / 502 |
intestine | 70% | 2290.85 | 674 / 966 | 93% | 32.63 | 492 / 527 |
breast | 66% | 251.09 | 301 / 459 | 93% | 16.27 | 1039 / 1118 |
stomach | 64% | 223.61 | 230 / 359 | 94% | 23.70 | 270 / 286 |
thymus | 64% | 199.25 | 421 / 653 | 80% | 8.85 | 482 / 605 |
skin | 62% | 197.74 | 1113 / 1809 | 74% | 7.71 | 351 / 472 |
liver | 72% | 219.73 | 162 / 226 | 58% | 4.10 | 236 / 406 |
kidney | 35% | 129.43 | 31 / 89 | 88% | 9.81 | 791 / 901 |
esophagus | 47% | 136.75 | 673 / 1445 | 75% | 5.92 | 138 / 183 |
uterus | 35% | 90.71 | 59 / 170 | 85% | 10.15 | 388 / 459 |
pancreas | 22% | 84.47 | 73 / 328 | 94% | 15.53 | 168 / 178 |
adrenal gland | 85% | 317.42 | 220 / 258 | 29% | 1.61 | 67 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.84 | 29 / 29 |
spleen | 100% | 6216.07 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.79 | 1 / 1 |
peripheral blood | 99% | 14217.65 | 923 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 15.08 | 44 / 45 |
brain | 20% | 67.48 | 541 / 2642 | 74% | 6.61 | 525 / 705 |
adipose | 79% | 407.22 | 949 / 1204 | 0% | 0 | 0 / 0 |
ovary | 13% | 32.45 | 23 / 180 | 56% | 3.56 | 241 / 430 |
blood vessel | 35% | 154.63 | 467 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 33% | 2.20 | 26 / 80 |
heart | 27% | 78.77 | 233 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 2.74 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0006641 | Biological process | triglyceride metabolic process |
GO_0006869 | Biological process | lipid transport |
GO_0042627 | Cellular component | chylomicron |
GO_0034362 | Cellular component | low-density lipoprotein particle |
GO_0005886 | Cellular component | plasma membrane |
GO_0034361 | Cellular component | very-low-density lipoprotein particle |
GO_0016020 | Cellular component | membrane |
GO_0030229 | Molecular function | very-low-density lipoprotein particle receptor activity |
Gene name | APOBR |
Protein name | Apolipoprotein B receptor (Apolipoprotein B-100 receptor) (Apolipoprotein B-48 receptor) (Apolipoprotein B48 receptor) (apoB-48R) |
Synonyms | APOB48R |
Description | FUNCTION: Macrophage receptor that binds to the apolipoprotein B48 (APOB) of dietary triglyceride (TG)-rich lipoproteins (TRL) or to a like domain of APOB in hypertriglyceridemic very low density lipoprotein (HTG-VLDL). Binds and internalizes TRL when out of the context of the macrophage. May provide essential lipids to reticuloendothelial cells. Could also be involved in foam cell formation with elevated TRL and remnant lipoprotein (RLP). Mediates the rapid high-affinity uptake of chylomicrons (CM), HTG-VLDL, and trypsinized (tryp) VLDL devoid of APOE in vitro in macrophages. . |
Accessions | ENST00000564831.6 [Q0VD83-4] Q0VD83 |